Figure 2: Saccade velocity and task efficiency for placebo (left panel) and caffeine (right panel) treatments.
From: Fatigue related impairments in oculomotor control are prevented by caffeine
(Panel a) - Percentage change in post exercise average saccade velocity compared to pre-exercise. Significance labelling above bars show one sample comparisons relative to baseline (0 min). (Panel b) - Congruent average saccade velocity pre exercise and post exercise in placebo and caffeine treatments. Each point represents mean saccade velocity ± 95% confidence interval for each participant. Dashed lines represent participants exhibiting a pre to post exercise change in congruent saccade velocity with an associated effect size >0.5. (Panel c) - Task efficiency (saccade latency divided by proportion of correct saccades). Significance labelling between congruent and incongruent saccade lines indicate a main effect of congruency. Left panel shows data collected in placebo, right panel shows data collected in caffeine trial. Data represent mean ± SE. *≤0.05.
